Investor profile
Sofinnova Partners has backed 79 European tech companies across 115 funding rounds between 2004 and 2026, joining rounds totalling €2.9B. Most active in Healthtech and Software. Data as of 21 Sept 2026.
Also recorded as: SOFINNOVA PARTNERS · Sofinnova Partners.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Artios | UK | 2 | €229M |
| GlycoEra | Switzerland | 2 | €157M |
| Noema Pharma | Switzerland | 2 | €134M |
| Amolyt Pharma | France | 1 | €129M |
| IOmx Therapeutics | Germany |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Artios | Series C | €130M | 2021-07 |
| Amolyt Pharma | Series C | €129M | 2023-01 |
| GlycoEra | Series B | €114M | 2025-05 |
| Noema Pharma |
| 2 |
| €105M |
| Tissium | France | 2 | €100M |
| SafeHeal | France | 4 | €91M |
| NanoPhoria | Italy | 1 | €84M |
| Moon Surgical | France | 2 | €81M |
| ObsEva | Switzerland | 2 | €80M |
| Merus | Netherlands | 1 | €73M |
| Bioptimus | France | 2 | €72M |
| Northsea Therapeutics | Netherlands | 1 | €71M |
| Inside Secure | France | 4 | €69M |
| F2G | UK | 1 | €69M |
| Neurent Medical | Ireland | 1 | €63M |
| Elicit Plant | France | 2 | €62M |
| haya therapeutics | Switzerland | 1 | €58M |
| Latent Labs | UK | 1 | €48M |
| Ascendis Pharma | Denmark | 1 | €48M |
| Microphyt | France | 2 | €44M |
| Breath Therapeutics | Germany | 1 | €44M |
| Aledia | France | 2 | €40M |
| Mironid | UK | 1 | €40M |
| Micropep | France | 3 | €40M |
| Auris Medical | Switzerland | 1 | €40M |
| Synthace | UK | 2 | €39M |
| MISSION Therapeutics | UK | 2 | €35M |
| Sphere Fluidics | UK | 1 | €34M |
| MedDay | France | 1 | €34M |
| Series B |
| €105M |
| 2023-03 |
| Artios | Series D+ | €99M | 2025-11 |
| NanoPhoria | Series A | €84M | 2025-10 |
| Merus | Series C | €73M | 2015-08 |
| Northsea Therapeutics | Other | €71M | 2021-12 |
| F2G | Other | €69M | 2022-08 |
| IOmx Therapeutics | Series B | €65M | 2021-10 |
